Inovalon (NASDAQ:INOV) Earns News Sentiment Rating of 0.04

Press coverage about Inovalon (NASDAQ:INOV) has been trending somewhat positive this week, Accern Sentiment Analysis reports. Accern identifies negative and positive news coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Inovalon earned a coverage optimism score of 0.04 on Accern’s scale. Accern also gave press coverage about the technology company an impact score of 47.412677472138 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

Here are some of the media headlines that may have effected Accern Sentiment Analysis’s rankings:

Inovalon (INOV) traded down $0.30 during trading hours on Friday, reaching $15.60. The company had a trading volume of 383,838 shares, compared to its average volume of 316,486. The firm has a market capitalization of $2,319.36, a price-to-earnings ratio of 75.71, a P/E/G ratio of 4.65 and a beta of 1.24. Inovalon has a 1 year low of $8.60 and a 1 year high of $17.80. The company has a current ratio of 5.62, a quick ratio of 5.62 and a debt-to-equity ratio of 0.31.

Inovalon (NASDAQ:INOV) last released its earnings results on Wednesday, November 1st. The technology company reported $0.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.08 by $0.01. The firm had revenue of $115.90 million for the quarter, compared to analyst estimates of $114.79 million. Inovalon had a return on equity of 4.63% and a net margin of 4.07%. Inovalon’s revenue was up 10.4% compared to the same quarter last year. During the same period in the previous year, the company earned $0.10 earnings per share. equities analysts anticipate that Inovalon will post 0.24 earnings per share for the current fiscal year.

A number of equities analysts have commented on the stock. KeyCorp reaffirmed a “hold” rating on shares of Inovalon in a report on Tuesday, September 12th. TheStreet upgraded Inovalon from a “d+” rating to a “c-” rating in a research note on Thursday, October 5th. BidaskClub cut Inovalon from a “hold” rating to a “sell” rating in a research note on Saturday. Zacks Investment Research cut shares of Inovalon from a “hold” rating to a “sell” rating in a research note on Tuesday, November 7th. Finally, Morgan Stanley upgraded shares of Inovalon from an “underweight” rating to an “equal weight” rating and lifted their price objective for the company from $9.00 to $14.00 in a research note on Tuesday, September 12th. Three analysts have rated the stock with a sell rating, six have given a hold rating and one has assigned a buy rating to the stock. The stock presently has an average rating of “Hold” and an average price target of $14.00.

In other Inovalon news, CEO Keith R. Dunleavy bought 62,000 shares of the stock in a transaction on Wednesday, September 13th. The shares were bought at an average price of $16.38 per share, with a total value of $1,015,560.00. Following the purchase, the chief executive officer now directly owns 270,000 shares in the company, valued at approximately $4,422,600. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Shauna L. Vernal sold 5,908 shares of Inovalon stock in a transaction dated Friday, November 17th. The shares were sold at an average price of $16.01, for a total value of $94,587.08. Following the transaction, the insider now directly owns 47,309 shares in the company, valued at approximately $757,417.09. The disclosure for this sale can be found here. Company insiders own 48.28% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This report was originally posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this report on another website, it was illegally copied and reposted in violation of United States & international copyright and trademark law. The legal version of this report can be read at

About Inovalon

Inovalon Holdings, Inc (Inovalon) is a technology company. The Company provides cloud-based platforms empowering a data-driven transformation from volume-based to value-based models to the healthcare industry. Leveraging large-scale data interconnectivity capabilities, unparalleled proprietary data sets, advanced analytics, data-driven intervention systems, and subject matter expertise, Inovalon enables the assessment and improvement of clinical and quality outcomes and financial performance across the healthcare ecosystem.

Insider Buying and Selling by Quarter for Inovalon (NASDAQ:INOV)

Receive News & Ratings for Inovalon Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inovalon Holdings Inc. and related companies with's FREE daily email newsletter.

Leave a Reply